The Xcelera R2.2 upgrade is a new version of the Xcelera multimodality cardiology image management, analysis and reporting solution, designed to offer enhanced functionality and greater workflow efficiency.
he Powerheart AED G3 is designed with Rescue Ready technology that self-checks all main components daily. The device ...
The process of the coronary CT angiography (CTA) becoming the preferred imaging modality is akin to the process of obtaining a pilot’s license.
Venous thromboembolism (VTE), and pulmonary embolism (PE) in particular, are among the most complex and dangerous acute ...
September 3, 2008 - Endologix Inc. yesterday said six-year patient follow-up data from the company’s Powerlink System ...
Boston Scientific launched its Atlantis 018 Peripheral Imaging Catheter, which reportedly brings existing 40MHz coronary ...
The FDA has approved the LipiScan Coronary Imaging System, an angiography laser scanner by InfraReDx Inc., which is intended to characterize fatty deposits in coronary vessel walls using near infrared diffuse spectroscopy.
Sponsored Content — According to the American Heart Association, cardiovascular disease is the leading cause of death in ...
The recently FDA-approved COGNIS CRT-D and the TELIGEN ICD from Boston Scientific are among the smallest and thinnest high-energy devices at 32.5 cc and 31.5 cc respectively, while less than 10 mm thick. Both devices offer extended battery longevity over previous company devices, self-correcting software and improved programming technology.
The use of embolic protection devices (EPD) during percutaneous cardiac procedures has helped reduce the number of complications due to debris being released into the bloodstream and causing blockages in smaller vessels. The devices are designed to capture and remove debris that may be dislodged during procedures. There are three classes of EPD devices:
In as much as the environment in which you live can affect your quality of life, so can the environment in which someone receives medical care affect patient outcome – at least in theory.
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
September 4, 2008 – St. Elizabeth, in Cincinnati, OH, which serves more than 300 stroke patients annually, is the first ...
September 3, 2008 - Edwards Lifesciences Corp. today said it received FDA approval for the Carpentier-Edwards PERIMOUNT ...
September 2, 2008 - The safety debate about drug-eluting stents (DES) is still ongoing and in these times of uncertainty ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
September 1, 2008 - Depression and heart disease are the two leading disorders with the strongest contributions to the ...
September 2, 2008 - Merit Medical Systems Inc., a manufacturer of disposable devices used primarily in cardiology and radiology procedures, today said five new products are scheduled to be introduced over the next few months.
Edwards Lifesciences Corp. produces the Carpentier-Edwards The PERIMOUNT Magna mitral valve was launched in Europe in September 2005. It incorporates features of the Carpentier-Edwards PERIMOUNT mitral valve, which has demonstrated 16 years of durability, including the treatment of the bovine pericardial tissue leaflets with the Carpentier-Edwards ThermaFix process. September 2008
September 03, 2008
